Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00996892
Title Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

lung non-small cell carcinoma

colorectal cancer

endometrial carcinoma

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

Cobimetinib + Pictilisib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Baltimore Maryland 21231 United States Details
Boston Massachusetts 02114 United States Details
Boston Massachusetts 02215 United States Details
Detroit Michigan 48201 United States Details
Oklahoma City Oklahoma 73104 United States Details
Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field